Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-01-02 @ 6:21 AM
Study NCT ID:
NCT06848556
Status:
TERMINATED
Last Update Posted:
2025-02-27
First Post:
2025-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Effect of Tirazamine on Primary Liver Cancer.
Sponsor:
Zhejiang Raygene Pharmaceuticals Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2025-02-19
First Submit QC Date:
None
Study First Post Date:
2025-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-24
Last Update Post Date:
2025-02-27
Last Update Post Date Type:
ACTUAL